SIM
CDTX

Spark Investment Management’s Cidara Therapeutics CDTX Stock Holding History

Spark Investment Management’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,307
Closed -$64K – 115
2020
Q1 		$64K Buy
1,307
+67
+5% +$4.01K 0.03% 311
2019
Q4 		$95K Buy
+1,240
New +$56.8K 0.01% 499
2019
Q3 		– Sell
-545
Closed -$18K – 410
2019
Q2 		$18K Sell
545
-1,853
-77% -$77K ﹤0.01% 544
2019
Q1 		$127K Sell
2,398
-202
-8% -$11.1K 0.01% 552
2018
Q4 		$122K Buy
+2,600
New +$186K 0.01% 545
2018
Q2 		– Sell
-605
Closed -$48K – 663
2018
Q1 		$48K Buy
+605
New +$82.6K ﹤0.01% 582
2017
Q2 		– Sell
-1,460
Closed -$227K – 776
2017
Q1 		$227K Buy
+1,460
New +$256K 0.01% 693
2016
Q4 		– Sell
-755
Closed -$172K – 783
2016
Q3 		$172K Buy
755
+20
+3% +$4.62K 0.01% 687
2016
Q2 		$151K Buy
735
+155
+27% +$37.5K 0.01% 662
2016
Q1 		$147K Sell
580
-1,065
-65% -$245K 0.01% 656
2015
Q4 		$564K Buy
+1,645
New +$494K 0.07% 349

Other funds holding CDTX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Spark Investment Management's CDTX Position: Q2 2020 in Review

Spark Investment Management sold out of Cidara Therapeutics (CDTX) in Q2 2020, closing a stake of 1,307 shares — an estimated $64K sold.

Spark Investment Management first reported a position in CDTX in Q4 2015 and held it in 11 quarters. The position peaked at $564K in Q4 2015. 65 funds tracked by Wall St. Rank hold CDTX as of Q2 2020.

  • Spark Investment Management reported no remaining Cidara Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Spark Investment Management sold 1,307 Cidara Therapeutics shares in Q2 2020, an estimated $64K.
  • Spark Investment Management first reported a position in Cidara Therapeutics in Q4 2015 and held it in 11 quarters.
  • Spark Investment Management's Cidara Therapeutics position peaked at $564K in Q4 2015.
  • 65 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q2 2020.

Based on Spark Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.